Literature DB >> 29074037

High-intensity focused ultrasound therapy.

Vincent Y T Cheung1.   

Abstract

High-intensity focused ultrasound therapy has received increasing interest in the management of benign uterine tumors. Either magnetic resonance or ultrasound imaging has been used to target and monitor the ablation process. This article provides an overview of the background, clinical use, treatment outcomes, and safety of high-intensity focused ultrasound in the treatment of uterine fibroids and adenomyosis, including a summary of clinical trials comparing magnetic resonance- or ultrasound-guided high-intensity focused ultrasound with other minimally invasive or surgical interventions. The potential of this treatment modality as an alternative uterus-sparing option for women with fibroids and adenomyosis is discussed.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  Adenomyosis; Fibroid; High-intensity focused ultrasound; Magnetic resonance-guided; Ultrasound-guided

Mesh:

Year:  2017        PMID: 29074037     DOI: 10.1016/j.bpobgyn.2017.09.002

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  11 in total

1.  Correction to: A feasibility analysis of the ArcBlate MR‑guided high‑intensity focused ultrasound system for the ablation of uterine fibroids.

Authors:  Chin-Jung Wang; Gigin Lin; Yi-Ting Huang; Cindy Hsuan Weng; Kai-Yun Wu; Yu-Ying Su; Yu-Shan Lin; Kit-Sum Mak
Journal:  Abdom Radiol (NY)       Date:  2022-01

2.  Evaluation of physician experience in achieving non-perfused volume ratio of high-intensity focused ultrasound ablation for uterine fibroids: a multicentre study.

Authors:  Xue Gong; Xinyue Zhang; Dang Liu; Chao Yang; Rong Zhang; Zhibo Xiao; Wenzhi Chen; Jinyun Chen
Journal:  J Int Med Res       Date:  2022-05       Impact factor: 1.573

3.  Comment on: Delayed intestinal perforation and vertebral osteomyelitis after high-intensity focused ultrasound treatment for uterine leiomyoma.

Authors:  Jennifer K Y Ko; Vincent Y T Cheung
Journal:  Obstet Gynecol Sci       Date:  2018-02-22

4.  Intermittent ice-cooling to prevent skin heat injury caused by high-intensity focused ultrasound therapy targeting desmoid-type fibromatosis: A case report.

Authors:  Liangyu Fang; Xiaoye Hu; Yinchuan Xu; Hongling Sun; Hong Shen
Journal:  Int J Nurs Sci       Date:  2020-12-18

5.  Neutrophil-mediated clinical nanodrug for treatment of residual tumor after focused ultrasound ablation.

Authors:  Jian Shen; Junnian Hao; Yini Chen; Hairong Liu; Jianrong Wu; Bing Hu; Yan Wang; Yuanyi Zheng; Xiaojun Cai
Journal:  J Nanobiotechnology       Date:  2021-10-29       Impact factor: 10.435

6.  Physician Experience in Technical Success of Achieving NPVR ≥ 80% of High-Intensity Focused Ultrasound Ablation for Uterine Fibroids: A Multicenter Study.

Authors:  Xue Gong; Xinyue Zhang; Dang Liu; Chao Yang; Rong Zhang; Zhibo Xiao; Wenzhi Chen; Jinyun Chen
Journal:  Front Med Technol       Date:  2022-03-08

7.  Intelligent Noise Reduction Algorithm to Evaluate the Correlation between Human Fat Deposits and Uterine Fibroids under Ultrasound Imaging.

Authors:  Yan Luo; Wenxia Huang; Kewei Zeng; Chunfeng Zhang; Chunyan Yu; Wencui Wu
Journal:  J Healthc Eng       Date:  2021-11-30       Impact factor: 2.682

Review 8.  Smart Nanoparticles for Chemo-Based Combinational Therapy.

Authors:  Binita Shrestha; Lijun Wang; Eric M Brey; Gabriela Romero Uribe; Liang Tang
Journal:  Pharmaceutics       Date:  2021-06-08       Impact factor: 6.525

9.  Health Education Using Telephone and WeChat in Treatment of Symptomatic Uterine Myoma with High-Intensity Focused Ultrasound.

Authors:  Qian Zou; Guangyu Zhang; Yan Liu
Journal:  Med Sci Monit Basic Res       Date:  2018-09-06

10.  A feasibility analysis of the ArcBlate MR-guided high-intensity focused ultrasound system for the ablation of uterine fibroids.

Authors:  Chin-Jung Wang; Gigin Lin; Yi-Ting Huang; Cindy Hsuan Weng; Kai-Yun Wu; Yu-Ying Su; Yu-Shan Lin; Kit-Sum Mak
Journal:  Abdom Radiol (NY)       Date:  2021-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.